(Q45140581)

English

Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8+ T-cell response compared with cyclosporine- or mycophenolate-treated patients

scientific article published in January 2013

Statements

Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8+ T-cell response compared with cyclosporine- or mycophenolate-treated patients (English)
Simone H C Havenith
Si La Yong
Karlijn A M I van Donselaar-van der Pant
Ineke J M ten Berge
Fréderike J Bemelman
1 January 2013
184-191

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit